ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 609,15
0,00%
Dow Jones
39 127,80
0,04%
DAX
18 155,24
-0,04%
Brent Oil
84,365
-0,12%
Bitcoin
60 637,25
-0,29%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Synergy Pharmaceuticals, Inc. (MM) (SGYPD)

  7. Synergy Pharmaceuticals, Inc. (MM) (SGYPD) Actualités

SGYPD

Synergy Pharmaceuticals, Inc. (MM) (SGYPD)

Synergy Pharmaceuticals, Inc. (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:SGYPD
DateHeureSourceTitreSymboleSociété
02/03/201901h13Dow Jones NewsSynergy Pharmaceuticals Is Approved to Sell Assets to Bausch HealthNASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
27/02/201901h07Dow Jones NewsBausch Health to Acquire Certain Assets of Synergy Pharmaceuticals Inc.NASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
17/12/201821h43Dow Jones NewsSynergy Pharmaceuticals Up 55% on Trulance Progress in CanadaNASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
12/12/201817h10Dow Jones NewsFormer Pharma Highflier Appreciates Bathroom Humor -- OverheardNASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
12/12/201814h18Dow Jones NewsBausch Health to Buy Synergy Pharmaceuticals Out of Bankruptcy for $200 Million--UpdateNASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
12/12/201813h14Dow Jones NewsBausch Health Agrees to Buy Synergy Pharmaceuticals for $200 MillionNASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
03/01/201222h44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
27/12/201122h05Edgar (US Regulatory)Current report filing (8-K)NASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
22/12/201112h01Edgar (US Regulatory)Notice of Effectiveness (EFFECT)NASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
21/12/201118h18Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(3) (424B3)NASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
19/12/201123h04Edgar (US Regulatory)Securities Registration Statement (simplified form) (S-3/A)NASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
13/12/201122h41Business WireSynergy Pharmaceuticals Announces Full Exercise of Over-Allotment Option by Aegis Capital Corp.NASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
13/12/201114h00PR Newswire (US)Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior V...NASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
13/12/201109h00Business WireSynergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. & its Chief Scientific Officer & Senior VP of...NASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
06/12/201123h00Business WireSynergy Pharmaceuticals Announces Closing of Public Offering of 1,875,000 UnitsNASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
01/12/201123h14Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(2) (424B2)NASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
01/12/201114h00Business WireSynergy Pharmaceuticals Inc. Announces Pricing of Public Offering of 1,875,000 Units, Listing on NASDAQ & Effectiveness of Re...NASDAQ:SGYPDSynergy Pharmaceuticals, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:SGYPD

Dernières Valeurs Consultées

EU
BN
Danone
EU
LR
Legrand
NASDAQ
GOOGL
Alphabet
EU
MC
Lvmh Moet Hennessy Louis...
EU
VK
Vallourec
NASDAQ
AMZN
Amazon.com
NYSE
KO
Coca Cola
NYSE
MRK
Merck
EU
ORA
Orange
EU
GLE
Societe Generale
NASDAQ
MSFT
Microsoft
EU
AI
Air Liquide
EU
PX1
CAC 40
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés